NASACORT AQ (triamcinolone acetonide) Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 2 years of age and older.

Administer NASACORT AQ (triamcinolone acetonide) Nasal Spray by the intranasal route only. Shake NASACORT AQ (triamcinolone acetonide) Nasal Spray well before each use.

Adults and Adolescents 12 Years of Age and Older

The recommended starting and maximum dose is 220 mcg per day as two sprays in each nostril once daily. Titrate an individual patient to the minimum effective dose to reduce the possibility of side effects. When the maximum benefit has been achieved and symptoms have been controlled, reducing the dose to 110 mcg per day (one spray in each nostril once a day) has been shown to be effective in maintaining control of the allergic rhinitis symptoms.

Children 2 to 12 Years of Age

Children 6 to 12 years of age: The recommended starting dose is 110 mcg per day given as one spray in each nostril once daily. Children not responding adequately to 110 mcg per day may use 220 mcg (2 sprays in each nostril) once daily. Once symptoms have been controlled, the dosage may be decreased to 110 mcg once daily.

Children 2 to 5 years of age: The recommended and maximum dose is 110 mcg per day given as one spray in each nostril once daily.

NASACORT AQ (triamcinolone acetonide) Nasal Spray is not recommended for children under 2 years of age.

Administration Information

Priming: Prime NASACORT AQ (triamcinolone acetonide) Nasal Spray before using for the first time by shaking the contents well and releasing 5 sprays into the air away from the face. It will remain adequately primed for two weeks. If the product is not used for more than 2 weeks, then it can be adequately reprimed with one spray. Shake NASACORT AQ (triamcinolone acetonide) Nasal Spray well before each use.

If adequate relief of symptoms has not been obtained after 3 weeks of treatment, NASACORT AQ (triamcinolone acetonide) Nasal Spray should be discontinued. [See WARNINGS AND PRECAUTIONS, Patient Counseling Information, and ADVERSE REACTIONS]

Dosage Forms And Strengths

NASACORT AQ (triamcinolone acetonide) Nasal Spray is a metered-dose pump spray containing the active ingredient triamcinolone acetonide. Each actuation delivers 55 mcg triamcinolone acetonide from the nasal actuator after an initial priming of 5 sprays. Each 16.5 gram bottle (120 actuations) contains 9.075 mg of triamcinolone acetonide. The bottle should be discarded when the labeled- number of actuations have been reached even though the bottle is not completely empty.

NASACORT AQ (triamcinolone acetonide) Nasal Spray, 55 mcg per spray, is supplied in a white high-density polyethylene container with a metered-dose pump unit, white nasal adapter, and patient instructions (NDC 0075-1506-16).

The contents of one 16.5 gram bottle provide 120 actuations. After 120 actuations, the amount of triamcinolone acetonide delivered per actuation may not be consistent and the unit should be discarded. Each actuation delivers 55 mcg triamcinolone acetonide from the nasal actuator after an initial priming of 5 sprays [See Administration Information].

In the Patient Package Information, patients are provided with a check-off form to track usage [See Patient Counseling Information].

Keep out of reach of children. Rx only

Storage

Store at Controlled Room Temperature, 20 to 25°C (68 to 77°F)

Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807. Tel: 800-981-2491. Customersupport.sanofi-aventis.us. FDA rev date: 9/19/2008

Last reviewed on RxList: 10/27/2008
This monograph has been modified to include the generic and brand name in many instances.